Aurobindo Pharma & promoters fined Rs22.7cr by Sebi on violation of norms

The pharma company and its promoters were penalized for violation of provisions of insider trading in relation to a licensing deal it had entered with Pfizer in 2009, reports said.

from India Infoline News Service https://ift.tt/2mdWwin